GT Biopharma, Inc. - FORM 10-K - EX-32.2 - CERTIFICATION SECTION 906 - March 31, 2015

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - GT Biopharma, Inc.Financial_Report.xls
EX-14.1 - CODE OF ETHICS - GT Biopharma, Inc.ex141.htm
EX-10.2 - EMPLOYMENT AGREEMENT OF ANTHONY CATALDO - GT Biopharma, Inc.ex102.htm
EX-32.1 - CERTIFICATION SECTION 906 - GT Biopharma, Inc.ex321.htm
EX-31.2 - CERTIFICATION SECTION 302 - GT Biopharma, Inc.ex312.htm
EX-31.1 - CERTIFICATION SECTION 302 - GT Biopharma, Inc.ex311.htm
EX-21.1 - SUBSIDIARIES OF OXIS INTERNATIONAL, INC. - GT Biopharma, Inc.ex211.htm
EX-10.1 - EMPLOYMENT AGREEMENT OF STEVEN WELDON - GT Biopharma, Inc.ex101.htm
10-K - OXIS INTERNATIONAL ANNUAL REPORT 2014 - GT Biopharma, Inc.oxisannualreport2014.htm

Exhibit 32.2

CERTIFICATION TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, I, Steven Weldon, Chief Financial Officer of OXIS International, Inc. (the “Company”), hereby certify that, to the best of my knowledge:

(i) the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2014 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
     
       
Date: March 31, 2015
By:
/s/ Steven Weldon
  
   
Name: Steven Weldon
  
   
Title: Chief Financial Officer, President and Director (Principal Financial Officer)
  
       


Stock widget

Investing forum

GT Biopharma, Inc. Reports